Insulin-like growth factors (IGFs), IGF receptors, and IGF-binding proteins: Roles in skeletal muscle growth and differentiation

General and Comparative Endocrinology

Volumn 167, Issue 3, 2010, Pages 344-351

  Duan, Cunming ^a,b   Ren, Hongxia ^a   Gao, Shan ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b OCEAN UNIVERSITY OF CHINA   (China)

Author keywords

Akt; HIF 1; Hypoxia; IGF; IGFBP; MAPK; MTOR; Myoblast; Proliferation

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN KINASE B; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN RECEPTOR;

AUTOCRINE EFFECT; BIOLOGICAL ACTIVITY; CELL DIFFERENTIATION; CELL HYPOXIA; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; GENE OVEREXPRESSION; GROWTH REGULATION; MOLECULAR DYNAMICS; MUSCLE DEVELOPMENT; MUSCLE GROWTH; MUSCLE METABOLISM; MYOBLAST; NONHUMAN; OXYGEN CONSUMPTION; PANCREAS ISLET BETA CELL; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; ANIMAL; BIOLOGICAL MODEL; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PHYSIOLOGY;

ANIMALS; CELL DIFFERENTIATION; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; MODELS, BIOLOGICAL; MUSCLE, SKELETAL; RECEPTORS, SOMATOMEDIN; SIGNAL TRANSDUCTION; SOMATOMEDINS;

EID: 77953356748     PISSN: 00166480     EISSN: 10956840     Source Type: Journal    
DOI: 10.1016/j.ygcen.2010.04.009     Document Type: Review

References (134)

1. Ayaso E., Nolan C.M., Byrnes L. Zebrafish insulin-like growth factor-I receptor: molecular cloning and developmental expression. Mol. Cell. Endocrinol. 2002, 191:137-148.
2. Baker J., Hardy M.P., Zhou J., Bondy C., Lupu F., Bellve A.R., Efstratiadis A. Effects of an IGF1 gene null mutation on mouse reproduction. Mol. Endocrinol. 1996, 10:903-918.
3. Baker J., Liu J.P., Robertson E.J., Efstratiadis A. Role of insulin-like growth-factors in embryonic and postnatal-growth. Cell 1993, 75:73-82.
4. Bamman M.M., Shipp J.R., Jiang J., Gower B.A., Hunter G.R., Goodman A., McLafferty C.L., Urban R.J. Mechanical load increases muscle IGF-I and androgen receptor mRNA concentrations in humans. Am. J. Physiol. Endocrinol. Metab. 2001, 280:E383-E390.
5. Barton-Davis E.R., Shoturma D.I., Musaro A., Rosenthal N., Sweeney H.L. Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function. Proc. Natl. Acad. Sci. USA 1998, 95:15603-15607.
6. Barton E.R., Morris L., Musaro A., Rosenthal N., Sweeney H.L. Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice. J. Cell Biol. 2002, 157:137-147.
7. Bayol S., Loughna P.T., Brownson C. Phenotypic expression of IGF-binding protein transcripts in muscle, in vitro and in vivo. Biochem. Biophys. Res. Commun. 2000, 273:282-286.
8. Brinkman A., Kortleve D.J., Zwarthoff E.C., Drop S.L.S. Mutations in the C-terminal part of insulin-like growth-factor (IGF)-binding protein-1 result in dimer formation and loss of IGF-binding capacity. Mol. Endocrinol. 1991, 5:987-994.
9. Bruick R.K. Oxygen sensing in the hypoxic response pathway: regulation of the hypoxia-inducible transcription factor. Genes Dev. 2003, 17:2614-2623.
10. Buckingham M., Bajard L., Chang T., Daubas P., Hadchouel J., Meilhac S., Montarras D., Rocancourt D., Relaix F. The formation of skeletal muscle: from somite to limb. J. Anat. 2003, 202:59-68.
11. Camarero G., Avendano C., Fernandez-Moreno C., Villar A., Contreras J., de Pablo F., Pichel J.G., Varela-Nieto I. Delayed inner ear maturation and neuronal loss in postnatal IGF-1-deficient mice. J. Neurosci. 2001, 21:7630-7641.
12. Carroll P.V., Christ E.R., Umpleby A.M., Gowrie I., Jackson N., Bowes S.B., Hovorka R., Croos P., Sonksen P.H., Russell-Jones D.L. IGF-I treatment in adults with type 1 diabetes - Effects on glucose and protein metabolism in the fasting state and during a hyperinsulinemic-euglycemic amino acid clamp. Diabetes 2000, 49:789-796.
13. Chelius D., Baldwin M.A., Lu X., Spencer E.M. Expression, purification and characterization of the structure and disulfide linkages of insulin-like growth factor-binding protein-4. J. Endocrinol. 2001, 168:283-296.
14. Cianfarani S., Geremia C., Puglianiello A., Maiorana A., Germani D. Late effects of disturbed IGF signaling in congenital diseases - intrauterine and postnatal growth retardation. Endrocr. Dev. 2007, 11:16-27.
15. Clemmons D.R. Use of mutagenesis to probe IGF-binding protein structure/function relationships. Endocr. Rev. 2001, 22:800-817.
16. Cobb L.J., Salih D.A.M., Gonzalez I., Tripathi G., Carter E.J., Lovett F., Holding C., Pell J.M. Partitioning of IGFBP-5 actions in myogenesis: IGF-independent anti-apoptotic function. J. Cell Sci. 2004, 117:1737-1746.
17. Coleman M.E., Demayo F., Yin K.C., Lee H.M., Geske R., Montgomery C., Schwartz R.J. Myogenic vector expression of insulin-like growth-factor-I stimulates muscle-cell differentiation and myofiber hypertrophy in transgenic mice. J. Biol. Chem. 1995, 270:12109-12116.
18. Coolican S.A., Samuel D.S., Ewton D.Z., McWade F.J., Florini J.R. The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways. J. Biol. Chem. 1997, 272:6653-6662.
19. D'Ercole A.J., Ye P., O'Kusky J.R. Mutant mouse models of insulin-like growth factor actions in the central nervous system. Neuropeptides 2002, 36:209-220.
20. Dai, W., Kamei, H., Zhao, Y., Ding, J., Du, Z., Duan, C., 2010. Duplicated zebrafish insulin-like growth factor-binding protein-5 genes with split functional domains: evidence for evolutionarily conserved IGF binding, nuclear localization, and transactivation activity. FASEB J. [Epub ahead of print] PMID: 20081093.
21. De Meyts P., Whittaker J. Structural biology of insulin and IGF1 receptors: Implications for drug design. Nat. Rev. Drug Discov. 2002, 1:769-783.
22. DeMambro V.E., Clemmons D.R., Horton L.G., Bouxsein M.L., Wood T.L., Beamer W.G., Canalis E., Rosen C.J. Gender-specific changes in bone turnover and skeletal architecture in Igfbp-2-null mice. Endocrinology 2008, 149:2051-2061.
23. Desbois-Mouthon C., Wendum D., Cadoret A., Rey C., Leneuve P., Blaise A., Housset C., Tronche F., Le Bouc Y., Holzenberger M. Hepatocyte proliferation during liver regeneration is impaired in mice with liver-specific IGF-1R knockout. FASEB J. 2006, 20:773-775.
24. Duan C.M., Clemmons D.R. Differential expression and biological effects of insulin-like growth factor-binding protein-4 and -5 in vascular smooth muscle cells. J. Biol. Chem. 1998, 273:16836-16842.
25. Duan C.M., Xu Q.J. Roles of insulin-like growth factor (IGF)-binding proteins in regulating IGF actions. Gen. Comp. Endocrinol. 2005, 142:44-52.
26. Dupont J., LeRoith D. Insulin and insulin-like growth factor I receptors: similarities and differences in signal transduction. Horm. Res. 2001, 55:22-26.
27. Eisen J.S. Zebrafish make a big splash. Cell 1996, 87:969-977.
28. Eivers E., McCarthy K., Glynn C., Nolan C.M., Byrnes L. Insulin-like growth factor (IGF) signaling is required for early dorso-anterior development of the zebrafish embryo. Int. J. Dev. Biol. 2004, 48:1131-1140.
29. El-Shewy H.M., Lee M.H., Obeid L.M., Jaffa A.A., Luttrell L.M. The insulin-like growth factor type 1 and insulin-like growth factor type 2/mannose-6-phosphate receptors independently regulate ERK1/2 activity in HEK293 cells. J. Biol. Chem. 2007, 282:26150-26157.
30. Emerson C.P.J. Skeletal myogenesis: genetics and embryology to the fore. Curr. Opin. Genet. Dev. 1993, 3:265-274.
31. Engert J.C., Berglund E.B., Rosenthal N. Proliferation precedes differentiation in IGF-I-stimulated myogenesis. J. Cell Biol. 1996, 135:431-440.
32. Ewton D.Z., Coolican S.A., Mohan S., Chernausek S.D., Florini J.R. Modulation of insulin-like growth factor actions in L6A1 myoblasts by insulin-like growth factor-binding protein (IGFBP)-4 and IGFBP-5: a dual role for IGFBP-5. J. Cell. Physiol. 1998, 177:47-57.
33. Firth S.M., Baxter R.C. Cellular actions of the insulin-like growth factor-binding proteins. Endocr. Rev. 2002, 23:824-854.
34. Florini J.R., Ewton D.Z., Coolican S.A. Growth hormone and the insulin-like growth factor system in myogenesis. Endocr. Rev. 1996, 17:481-517.
35. Florini J.R., Ewton D.Z., Magri K.A., Mangiacapra F.J. Igfs and muscle differentiation. Adv. Exp. Med. Biol. 1993, 343:319-326.
36. Florini J.R., Magri K.A., Ewton D.Z., James P.L., Grindstaff K., Rotwein P.S. Spontaneous differentiation of skeletal myoblasts is dependent upon autocrine secretion of insulin-like growth factor-II. J. Biol. Chem. 1991, 266:15917-15923.
37. Forbes B.E., Turner D., Hodge S.J., McNeil K.A., Forsberg G., Wallace J.C. Localization of an insulin-like growth factor (IGF)-binding site of bovine IGF binding protein-2 using disulfide mapping and deletion mutation analysis of the C-terminal domain. J. Biol. Chem. 1998, 273:4647-4652.
38. George M., Ayuso E., Casellas A., Costa C., Devedjian J.C., Bosch F. Beta cell expression of IGF-I leads to recovery from type 1 diabetes. J. Clin. Invest. 2002, 109:1153-1163.
39. Gordan J.D., Thompson C.B., Simon M.C. HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation. Cancer cell 2007, 12:108-113.
40. Green B.N., Jones S.B., Streck R.D., Wood T.L., Rotwein P., Pintar J.E. Distinct expression patterns of insulin-like growth-factor-binding-proteins 2 and 5 during petal and postnatal-development. Endocrinology 1994, 134:954-962.
41. Guler H.P., Zapf J., Froesch E.R. Short-term metabolic effects of recombinant human insulin-like growth factor-I in healthy adults. N. Engl. J. Med. 1987, 317:137-140.
42. Hambrecht R., Schulze P.C., Gielen S., Linke A., Mobius-Winkler S., Erbs S., Kratzsch J., Schubert A., Adams V., Schuler G. Effects of exercise training on insulin-like growth factor-I expression in the skeletal muscle of non-cachectic patients with chronic heart failure. Eur. J. Cardiocasc. Prev. Rehabil. 2005, 12:401-406.
43. Hobba G.D., Lothgren A., Holmberg E., Forbes B.E., Francis G.L., Wallace J.C. Alanine screening mutagenesis establishes tyrosine 60 of bovine insulin-like growth factor-binding protein-2 as a determinant of insulin-like growth factor-binding. J. Biol. Chem. 1998, 273:19691-19698.
44. Hsieh T., Gordon R.E., Clemmons D.R., Busby W.H., Duan C.M. Regulation of vascular smooth muscle cell responses to insulin-like growth factor (IGF)-I by local IGF-binding proteins. J. Biol. Chem. 2003, 278:42886-42892.
45. James P.L., Jones S.B., Busby W.H., Clemmons D.R., Rotwein P. A highly conserved insulin-like growth factor-binding protein (Igfbp-5) is expressed during myoblast differentiation. J. Biol. Chem. 1993, 268:22305-22312.
46. James P.L., Stewart C.E.H., Rotwein P. Insulin-like growth factor-binding protein-5 modulates muscle differentiation through an insulin-like growth factor-dependent mechanism. J. Cell Biol. 1996, 133:683-693.
47. Jiang B.H., Aoki M., Zheng J.Z., Li J., Vogt P.K. Myogenic signaling of phosphatidylinositol 3-kinase requires the serine-threonine kinase Akt protein kinase B. Proc. Natl. Acad. Sci. USA 1999, 96:2077-2081.
48. Jogie-Brahim S., Feldman D., Oh Y. Unraveling insulin-like growth factor-binding protein-3 actions in human disease. Endocr. Rev. 2009, 30:417-437.
49. Jones J.I., Clemmons D.R. Insulin-like growth-factors and their binding-proteins - biological actions. Endocr. Rev. 1995, 16:3-34.
50. Jones J.I., Gockerman A., Busby W.H., Camachohubner C., Clemmons D.R. Extracellular-matrix contains insulin-like growth-factor-binding protein-5 - potentiation of the effects of Igf-I. J. Cell Biol. 1993, 121:679-687.
51. Kajimura S., Aida K., Duan C.M. Insulin-like growth factor-binding protein-1 (IGFBP-1) mediates hypoxia-induced embryonic growth and developmental retardation. Proc. Natl. Acad. Sci. USA 2005, 102:1240-1245.
52. Kajimura S., Aida K., Duan C.M. Understanding hypoxia-induced gene expression in early development: in vitro and in vivo analysis of hypoxia-inducible factor 1-regulated zebra fish insulin-like growth factor-binding protein 1 gene expression. Mol. Cell. Biol. 2006, 26:1142-1155.
53. Kaliman P., Vinals F., Testar X., Palacin M., Zorzano A. Phosphatidylinositol 3-kinase inhibitors block differentiation of skeletal muscle cells. J. Biol. Chem. 1996, 271:19146-19151.
54. Kamei, H., Lu, L., Jiao, S., Li, Y., Gyrup, C., Laursen, L.S., Oxvig, C., Zhou, J.F., Duan, C.M., 2008. Duplication and diversification of the hypoxia-inducible IGFBP-1 gene in zebrafish. PloS One 3.
55. Kaspar B.K., Llado J., Sherkat N., Rothstein J.D., Gage F.H. Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science 2003, 301:839-842.
56. Kloting N., Koch L., Wunderlich T., Kern M., Ruschke K., Krone W., Bruning J.C., Bluher M. Autocrine IGF-1 action in adipocytes controls systemic IGF-1 concentrations and growth. Diabetes 2008, 57:2074-2082.
57. Kornfeld S. Structure and function of the mannose 6-phosphate insulin-like growth factor-II receptors. Annu. Rev. Biochem. 1992, 61:307-330.
58. Kuang S., Gillespie M.A., Rudnicki M.A. Niche regulation of muscle satellite cell self-renewal and differentiation. Cell Stem Cell 2008, 2:22-31.
59. Kuang S., Rudnicki M.A. The emerging biology of satellite cells and their therapeutic potential. Trends Mol. Med. 2008, 14:82-91.
60. Kulkarni R.N., Holzenberger M., Shih D.Q., Ozcan U., Stoffel M., Magnuson M.A., Kahn C.R. Beta-cell-specific deletion of the Igf1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter beta-cell mass. Nat. Genet. 2002, 31:111-115.
61. Lassar A., Munsterberg A. Wiring diagrams - regulatory circuits and the control of skeletal myogenesis. Curr. Opin. Cell Biol. 1994, 6:432-442.
62. Lau M.M.H., Stewart C.E.H., Liu Z.Y., Bhatt H., Rotwein P., Stewart C.L. Loss of the imprinted Igf2/cation-independent mannose 6-phosphate receptor results in fetal overgrowth and perinatal lethality. Genes Dev. 1994, 8:2953-2963.
63. Lawlor M.A., Feng X.H., Everding D.R., Sieger K., Stewart C.E.H., Rotwein P. Dual control of muscle cell survival by distinct growth factor-regulated signaling pathways. Mol. Cell. Biol. 2000, 20:3256-3265.
64. Lawlor M.A., Rotwein P. Coordinate control of muscle cell survival by distinct insulin-like growth factor activated signaling pathways. J. Cell Biol. 2000, 151:1131-1140.
65. Lawlor M.A., Rotwein P. Insulin-like growth factor-mediated muscle cell survival: Central roles for Akt and cyclin-dependent kinase inhibitor p21. Mol. Cell. Biol. 2000, 20:8983-8995.
66. Le Q.T., Denko N.C., Giaccia A.J. Hypoxic gene expression and metastasis. Cancer Metastasis Rev. 2004, 23:293-310.
67. Le Roith D., Bondy C., Yakar S., Liu J.L., Butler A. The somatomedin hypothesis: 2001. Endocr. Rev. 2001, 22:53-74.
68. LeRoith D., Roberts C.T. The insulin-like growth factor system and cancer. Cancer Lett. 2003, 195:127-137.
69. Leu J.I., Crissey M.A.S., Craig L.E., Taub R. Impaired hepatocyte DNA synthetic response posthepatectomy in insulin-like growth factor-binding protein 1-deficient mice with defects in C/EBP beta and mitogen-activated protein kinase/extracellular signal-regulate kinase regulation. Mol. Cell. Biol. 2003, 23:1251-1259.
70. Leu J.I., Crissey M.A.S., Taub R. Massive hepatic apoptosis associated with TGF-beta 1 activation after Fas ligand treatment of IGF-binding protein-1-deficient mice. J. Clin. Invest. 2003, 111:129-139.
71. Li W.L., Fawcett J., Widmer H.R., Fielder P.J., Rabkin R., Keller G.A. Nuclear transport of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in opossum kidney cells. Endocrinology 1997, 138:1763-1766.
72. Li Y., Xiang J.H., Duan C.M. Insulin-like growth factor-binding protein-3 plays an important role in regulating pharyngeal skeleton and inner ear formation and differentiation. J. Biol. Chem. 2005, 280:3613-3620.
73. Liu J.P., Baker J., Perkins A.S., Robertson E.J., Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor-I (IGF-1) and type-1 IGF receptor (IGF1R). Cell 1993, 75:59-72.
74. Mason J.L., Xuan S.H., Dragatsis I., Efstratiadis A., Goldman J.E. Insulin-like growth factor (IGF) signaling through type 1 IGF receptor plays an important role in remyelination. J. Neurosci. 2003, 23:7710-7718.
75. Mathews L.S., Hammer R.E., Behringer R.R., Dercole A.J., Bell G.I., Brinster R.L., Palmiter R.D. Growth enhancement of transgenic mice expressing human insulin-like growth factor-I. Endocrinology 1988, 123:2827-2833.
76. Maures T., Chan S.J., Xu B., Sun H., Ding J., Duan C.M. Structural, biochemical, and expression analysis of two distinct insulin-like growth factor I receptors and their ligands in zebrafish. Endocrinology 2002, 143:1858-1871.
77. Maures T.J., Duan C.M. Structure, developmental expression, and physiological regulation of zebrafish IGF-binding protein-1. Endocrinology 2002, 143:2722-2731.
78. Morison I.M., Becroft D.M., Taniguchi T., Woods C.G., Reeve A.E. Somatic overgrowth associated with overexpression of insulin-like growth factor II. Nat. Med. 1996, 2:311-316.
79. Morison I.M., Reeve A.E. Insulin-like growth factor 2 and overgrowth: molecular biology and clinical implications. Mol. Med. Today 1998, 4:110-115.
80. Moses A.C., Young S.C.J., Morrow L.A., Obrien M., Clemmons D.R. Recombinant human insulin-like growth factor I increases insulin sensitivity and improve glycemic control in type II diabetes. Diabetes 1996, 45:91-100.
81. Mukherjee A., Wilson E.M., Rotwein P. Insulin-like growth factor (IGF)-binding protein-5 blocks skeletal muscle differentiation by inhibiting IGF actions. Mol. Endocrinol. 2008, 22:206-215.
82. Musaro A., Giacinti C., Borsellino G., Dobrowolny G., Pelosi L., Cairns L., Ottolenghi S., Cossu G., Bernardi G., Battistini L., Molinaro M., Rosenthal N. Stem cell-mediated muscle regeneration is enhanced by local isoform of insulin-like growth factor 1. Proc. Natl. Acad. Sci. USA 2004, 101:1206-1210.
83. Musaro A., McCullagh K., Paul A., Houghton L., Dobrowolny G., Molinaro M., Barton E.R., Sweeney H.L., Rosenthal N. Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nat. Genet. 2001, 27:195-200.
84. Neumann G.M., Bach L.A. The N-terminal disulfide linkages of human insulin-like growth factor-binding protein-6 (hIGFBP-6) and hIGFBP-1 are different as determined by mass spectrometry. J. Biol. Chem. 1999, 274:14587-14594.
85. Ning Y., Hoang B., Schuller A.G.P., Cominski T.P., Hsu M.S., Wood T.L., Pintar J.E. Delayed mammary gland involution in mice with mutation of the insulin-like growth factor-binding protein 5 gene. Endocrinology 2007, 148:2138-2147.
86. Ning Y., Schuller A.G.P., Bradshaw S., Rotwein P., Ludwig T., Frystyk J., Pintar J.E. Diminished growth and enhanced glucose metabolism in triple knockout mice containing mutations of insulin-like growth factor-binding protein-3,-4, and-5. Mol. Endocrinol. 2006, 20:2173-2186.
87. Ning Y., Schuller A.G.P., Conover C.A., Pintar J.E. Insulin-like growth factor (IGF)-binding protein-4 is both a positive and negative regulator of IGF activity in vivo. Mol. Endocrinol. 2008, 22:1213-1225.
88. Norby F.L., Wold L.E., Duan J.H., Hintz K.K., Ren J. IGF-I attenuates diabetes-induced cardiac contractile dysfunction in ventricular myocytes. Am. J. Physiol. Endocrinol. Metab. 2002, 283:E658-E666.
89. Olson E.N. Myod family - a paradigm for development - comment. Genes Dev. 1990, 4:1454-1461.
90. Pera E.M., Wessely O., Li S.Y., De Robertis E.M. Neural and head induction by insulin-like growth factor signals. Dev. Cell 2001, 1:655-665.
91. Pette D. The adaptive potential of skeletal muscle fibers. Can. J. Appl. Physiol. 2002, 27:423-448.
92. Philippou A., Halapas A., Maridaki M., Koutsilieris M. Type I insulin-like growth factor receptor signaling in skeletal muscle regeneration and hypertrophy. J. Musculoskelet. Neuronal. Interact. 2007, 7:208-218.
93. Phillips S.M. Resistance exercise: good for more than just grandma and grandpa's muscles. Appl. Physiol. Nutr. Metab. Physiol. Appliquee Nutr. Metab. 2007, 32:1198-1205.
94. Powellbraxton L., Hollingshead P., Warburton C., Dowd M., Pittsmeek S., Dalton D., Gillett N., Stewart T.A. IGF-I is required for normal embryonic growth in mice. Genes Dev. 1993, 7:2609-2617.
95. Radulescu R.T. From insulin, retinoblastoma protein and the insulin-receptor to a new model on growth-factor specificity - the nucleocrine pathway. J. Endocrinol. 1995, 146:365-368.
96. Rajaram S., Baylink D.J., Mohan S. Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. Endocr. Rev. 1997, 18:801-831.
97. Ren, H.X., Accili, D., Duan, C.M., 2010. Hypoxia converts the myogenic action of insulin-like growth factors into mitogenic action by differentially regulating multiple signaling pathways. Proc. Natl. Acad. Sci. USA. 2010 Mar 15. [Epub ahead of print] PMID: 20231451.
98. Ren H.X., Yin P., Duan C.M. IGFBP-5 regulates muscle cell differentiation by binding to IGF-II and switching on the IGF-II auto-regulation loop. J. Cell Biol. 2008, 182:979-991.
99. Richard-Parpaillon L., Heligon C., Chesnel F., Boujard D., Philpott A. The IGF pathway regulates head formation by inhibiting Wnt signaling in Xenopus. Dev. Biol. 2002, 244:407-417.
100. Rommel C., Bodine S.C., Clarke B.A., Rossman R., Nunez L., Stitt T.N., Yancopoulos G.D., Glass D.J. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat. Cell Biol. 2001, 3:1009-1013.
101. Rommel C., Clarke B.A., Zimmermann S., Nunez L., Rossman R., Reid K., Moelling K., Yancopoulos G.D., Glass D.J. Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt. Science 1999, 286:1738-1741.
102. Rotwein P., James P.L., Kou K. Rapid activation of insulin-like growth factor-binding protein-5 gene-transcription during myoblast differentiation. Mol. Endocrinol. 1995, 9:913-923.
103. Salih D.A.M., Tripathi G., Holding C., Szestak T.A.M., Gonzalez M.L., Carter E.J., Cobb L.J., Eisemann J.E., Pell J.M. Insulin-like growth factor-binding protein 5 (Igfbp5) compromises survival, growth, muscle development, and fertility in mice. Proc. Natl. Acad. Sci. USA 2004, 101:4314-4319.
104. Schedlich L.J., Le Page S.L., Firth S.M., Briggs L.J., Jans D.A., Baxter R.C. Nuclear import of insulin-like growth factor-binding protein-3 and-5 is mediated by the importin beta subunit. J. Biol. Chem. 2000, 275:23462-23470.
105. Schedlich L.J., Young T.F., Firth S.M., Baxter R.C. Insulin-like growth factor-binding protein (IGFBP)-3 and IGFBP-5 share a common nuclear transport pathway in T47D human breast carcinoma cells. J. Biol. Chem. 1998, 273:18347-18352.
106. Schlueter P.J., Peng G., Westerfield M., Duan C. Insulin-like growth factor signaling regulates zebrafish embryonic growth and development by promoting cell survival and cell cycle progression. Cell Death Differ. 2007, 14:1095-1105.
107. Schlueter P.J., Royer T., Farah M.H., Laser B., Chan S.J., Steiner D.F., Duan C.M. Gene duplication and functional divergence of the zebrafish insulin-like growth factor 1 receptors. FASEB J. 2006, 20:1230-1232.
108. Semenza G.L. HIF-1 and human disease: one highly involved factor. Genes Dev. 2000, 14:1983-1991.
109. Semenza G.L. Life with oxygen. Science 2007, 318:62-64.
110. Silha J.V., Murphy L.J. Minireview: insights from insulin-like growth factor-binding protein transgenic mice. Endocrinology 2002, 143:3711-3714.
111. Stewart C.E.H., James P.L., Fant M.E., Rotwein P. Overexpression of insulin-like growth factor-II induces accelerated myoblast differentiation. J. Cell. Physiol. 1996, 169:23-32.
112. Taguchi A., White M.F. Insulin-like signaling, nutrient homeostasis, and life span. Annu. Rev. Physiol. 2008, 70:191-212.
113. Tomas F.M., Knowles S.E., Owens P.C., Chandler C.S., Francis G.L., Read L.C., Ballard F.J. Insulin-like growth factor-I (IGF-I) and especially IGF-I variants are anabolic in dexamethasone-treated rats. Biochem. J. 1992, 282:91-97.
114. Ueki I., Ooi G.T., Tremblay M.L., Hurst K.R., Bach L.A., Boisclair Y.R. Inactivation of the acid labile subunit gene in mice results in mild retardation of postnatal growth despite profound disruptions in the circulating insulin-like growth factor system. Proc. Natl. Acad. Sci. USA 2000, 97:6868-6873.
115. Wang X.L., Lu L., Li L., Li Y.M., Chen C., Feng Q., Zhang C., Duan C. Molecular and functional characterization of two distinct IGF-binding protein-6 genes in zebrafish. Am. J. Physiol. 2009, 296:R1348-R1357.
116. Weintraub H. The MyoD family and myogenesis - redundancy, networks, and thresholds. Cell 1993, 75:1241-1244.
117. White M.F. Insulin signaling in health and disease. Science 2003, 302:1710-1711.
118. Wilson E.M., Rotwein P. Selective control of skeletal muscle differentiation by Akt1. J. Biol. Chem. 2007, 282:5106-5110.
119. Wilson E.M., Tureckova J., Rotwein P. Permissive roles of phosphatidyl inositol 3-kinase and Akt in skeletal myocyte maturation. Mol. Biol. Cell 2004, 15:497-505.
120. Wood, A.W., Duan, C.M., Bern, H.A., 2005a. Insulin-like growth factor signaling in fish. In: International Review of Cytology - A Survey of Cell Biology, 243, 215-285.
121. Wood A.W., Schlueter P.J., Duan C. Targeted knockdown of insulin-like growth factor-binding protein-2 disrupts cardiovascular development in zebrafish embryos. Mol. Endocrinol. 2005, 19:1024-1034.
122. Wood T.L., Rogler L.E., Czick M.E., Schuller A.G.P., Pintar J.E. Selective alterations in organ sizes in mice with a targeted disruption of the insulin-like growth factor-binding protein-2 gene. Mol. Endocrinol. 2000, 14:1472-1482.
123. Woods K.A., CamachoHubner C., Savage M.O., Clark A.J.L. Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. N. Engl. J. Med. 1996, 335:1363-1367.
124. Wraight C.J., Liepe I.J., White P.J., Hibbs A.R., Werther G.A. Intranuclear localization of insulin-like growth factor-binding protein-3 (IGFBP-3) during cell division in human keratinocytes. J. Invest. Dermatol. 1998, 111:239-242.
125. Wright W.E. Muscle basic helix-loop-helix proteins and the regulation of myogenesis. Curr. Opin. Genet. Dev. 1992, 2:243-248.
126. Wylie A.A., Pulford D.J., McVie-Wylie A.J., Waterland R.A., Evans H.K., Chen Y.T., Nolan C.M., Orton T.C., Jirtle R.L. Tissue-specific inactivation of murine M6P/IGF2R. Am. J. Pathol. 2003, 162:321-328.
127. Xu Q.J., Li S.H., Zhao Y., Maures T.J., Yin P., Duan C.M. Evidence that IGF binding protein-5 functions as a ligand-independent transcriptional regulator in vascular smooth muscle cells. Circ. Res. 2004, 94:E46-E54.
128. Yamada P.M., Lee K.W. Perspectives in mammalian IGFBP-3 biology: local vs. systemic action. Am. J. Physiol.-Cell Ph. 2009, 296:C954-C976.
129. Zeslawski W., Beisel H.G., Kamionka M., Kalus W., Engh R.A., Huber R., Lang K., Holak T.A. The interaction of insulin-like growth factor-I with the N-terminal domain of IGFBP-5. EMBO J. 2001, 20:3638-3644.
130. Zhang M., Xuan S.H., Bouxsein M.L., von Stechow D., Akeno N., Faugere M.C., Malluche H., Zhao G.S., Rosen C.J., Efstratiadis A., Clemens T.L. Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization. J. Biol. Chem. 2002, 277:44005-44012.
131. Zhao G., Monier-Faugere M.C., Langub M.C., Geng Z., Nakayama T., Pike J.W., Chernausek S.D., Rosen C.J., Donahue L.R., Malluche H.H., Fagin J.A., Clemens T.L. Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice. Increased trabecular bone volume without increased osteoblast proliferation. Endocrinology 2000, 141:2674-2682.
132. Zhao Y., Yin P., Bach L.A., Duan C.M. Several acidic amino acids in the N-domain of insulin-like growth factor-binding protein-5 are important for its transactivation activity. J. Biol. Chem. 2006, 281:14184-14191.
133. Zhou J., Li W., Kamei H., Duan C. Duplication of the IGFBP-2 gene in teleost fish: Protein structure and functionality conservation and gene expression divergence. PLoS One 2008, 3:e3926.
134. Zou S., Kamei H., Modi Z., Duan C. Zebrafish IGF genes gene duplication conservation and divergence and novel roles in midline and notochord development. PLoS One 2009, 4:e7026.